Evidence map›Paper›PMID 26309148›Full record

ArticleJournal of medicinal chemistry2015

6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors.

Niyada Hin, Bridget Duvall, Dana Ferraris, Jesse Alt, Ajit G Thomas, Rana Rais, Camilo Rojas, Ying Wu, Krystyna M Wozniak, Barbara S Slusher and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Exploring Water-Soluble South AfricanCurrent issues in molecular biology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Niyada HinBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Bridget DuvallBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Dana FerrarisBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Jesse AltBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Ajit G ThomasBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Rana RaisBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Camilo RojasBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Ying WuBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Krystyna M WozniakBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Barbara S SlusherBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Takashi TsukamotoBrain Science Institute, ‡Department of Neurology, and §Department of Molecular and Comparative Pathobiology, Johns Hopkins University , Baltimore, Maryland 21205, United States.
Johns Hopkins University · US

Funding

DAAO Inhibitors for the treatment of SchizophreniaR01MH091387 · NIMH · JOHNS HOPKINS UNIVERSITY · PI TSUKAMOTO, TAKASHI · 2011 to 2014
$2.1M
NIMH NIH HHS R01 MH091387NIMH NIH HHS R01MH091387
6 · The paper itself

Abstract

A series of 2-substituted 6-hydroxy-1,2,4-triazine-3,5(2H,4H)-dione derivatives were synthesized as inhibitors of D-amino acid oxidase (DAAO). Many compounds in this series were found to be potent DAAO inhibitors, with IC50 values in the double-digit nanomolar range. The 6-hydroxy-1,2,4-triazine-3,5(2H,4H)-dione pharmacophore appears metabolically resistant to O-glucuronidation unlike other structurally related DAAO inhibitors. Among them, 6-hydroxy-2-(naphthalen-1-ylmethyl)-1,2,4-triazine-3,5(2H,4H)-dione 11h was found to be selective over a number of targets and orally available in mice. Furthermore, oral coadministration of D-serine with 11h enhanced the plasma levels of D-serine in mice compared to the oral administration of D-serine alone, demonstrating its ability to serve as a pharmacoenhancer of D-serine.

Indexed as

AnimalsBiological AvailabilityCell LineD-Amino-Acid OxidaseDrug InteractionsHumansMaleMiceModels, MolecularProtein BindingReceptors, N-Methyl-D-AspartateSerineStereoisomerismStructure-Activity RelationshipTriazines6-hydroxy-2-(naphthalen-1-ylmethyl)-1,2,4-triazine-3,5(2H,4H)-dioneD-Amino-Acid OxidaseReceptors, N-Methyl-D-AspartateSerineTriazines

Identifiers

PMID26309148
PMCPMC5003509
OpenAlexW1142990347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.